[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 953 Introduced in House (IH)]
114th CONGRESS
1st Session
H. R. 953
To authorize the Attorney General to award grants to address the
national epidemics of prescription opioid abuse and heroin use.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
February 12, 2015
Mr. Sensenbrenner (for himself, Mr. Ryan of Ohio, Ms. Duckworth, Mr.
Chabot, Mr. Marino, Mr. Scott of Virginia, and Mr. Joyce) introduced
the following bill; which was referred to the Committee on the
Judiciary, and in addition to the Committees on Energy and Commerce and
Education and the Workforce, for a period to be subsequently determined
by the Speaker, in each case for consideration of such provisions as
fall within the jurisdiction of the committee concerned
_______________________________________________________________________
A BILL
To authorize the Attorney General to award grants to address the
national epidemics of prescription opioid abuse and heroin use.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE; TABLE OF CONTENTS.
(a) Short Title.--This Act may be cited as the ``Comprehensive
Addiction and Recovery Act of 2015''.
(b) Table of Contents.--The table of contents for this Act is as
follows:
Sec. 1. Short title; table of contents.
Sec. 2. Findings.
Sec. 3. Definitions.
TITLE I--PREVENTION AND EDUCATION
Sec. 101. Development of best prescribing practices.
Sec. 102. National education campaign.
Sec. 103. Community-based coalition enhancement grants to address local
drug crises.
TITLE II--LAW ENFORCEMENT AND TREATMENT
Sec. 201. Treatment alternative to incarceration programs.
Sec. 202. Law enforcement naloxone training and implementation
demonstration.
Sec. 203. Prescription drug take back expansion.
TITLE III--TREATMENT AND RECOVERY
Sec. 301. Evidence-based opioid and heroin treatment and interventions
demonstration.
Sec. 302. Criminal justice medication assisted treatment and
interventions demonstration.
Sec. 303. National youth recovery initiative.
Sec. 304. Building communities of recovery.
TITLE IV--ADDRESSING COLLATERAL CONSEQUENCES
Sec. 401. Correctional education demonstration grant program.
Sec. 402. Revision of FAFSA form.
Sec. 403. National Task Force on Recovery and Collateral Consequences.
TITLE V--ADDICTION AND TREATMENT SERVICES FOR WOMEN, FAMILIES, AND
VETERANS
Sec. 501. Authority to award competitive grants to address opioid and
heroin abuse by pregnant and parenting
female offenders.
Sec. 502. Grants for family-based substance abuse treatment.
Sec. 503. Veterans' treatment courts.
TITLE VI--INCENTIVIZING STATE COMPREHENSIVE INITIATIVES TO ADDRESS
OPIOID AND HEROIN ABUSE
Sec. 601. State demonstration grants for comprehensive opioid abuse
response.
TITLE VII--OFFSET; GAO REPORT
Sec. 701. Offset.
Sec. 702. GAO report on IMD exclusion.
SEC. 2. FINDINGS.
Congress finds the following:
(1) The abuse of heroin and prescription painkillers is
having a devastating effect on public health and safety in
communities across the United States. According to the Centers
for Disease Control and Prevention, drug overdose deaths now
surpass traffic crashes in the number of deaths caused by
injury in the United States. In 2011, an average of about 110
people in the United States died from drug overdose every day.
(2) Law enforcement officials and treatment experts
throughout the country report that many prescription opioid
users have turned to heroin as a cheaper or more easily
obtained alternative to prescription drugs.
(3) Opioid pain relievers are the most widely misused or
abused controlled prescription drugs (commonly referred to as
``CPDs'') and are involved in most CPD-related overdose
incidents. According to the Drug Abuse Warning Network
(commonly known as ``DAWN''), the estimated number of emergency
department visits involving nonmedical use of prescription
opiates or opioids increased by 112 percent between 2006 and
2010, from 84,671 to 179,787.
(4) According to a report by the National Association of
State Alcohol and Drug Abuse Directors (commonly referred to as
``NASADAD''), 37 States reported an increase in admissions to
treatment for heroin use during the past 2 years, while
admissions to treatment for prescription opiates increased 500
percent from 2000 to 2012.
(5) Substance use disorders are a treatable disease.
Discoveries in the science of addiction have led to advances in
the treatment of substance use disorders that help people stop
abusing drugs and prescription medications and resume their
productive lives.
(6) According to the National Survey on Drug Use and
Health, approximately 22,700,000 people in the United States
needed substance use disorder treatment in 2013, but only
2,500,000 people received it. Furthermore, current treatment
services are not adequate to meet demand. According to a report
commissioned by SAMHSA, there are approximately 32 providers
for every 1,000 individuals needing substance use disorder
treatment. In some States, the ratio is much lower.
(7) Effective substance abuse prevention can yield major
economic dividends.
(8) According to the National Institute on Drug Abuse, when
schools and communities properly implement science-validated
substance abuse prevention programs, abuse of alcohol, tobacco,
and illicit drugs is reduced. Such programs help teachers,
parents, and healthcare professionals shape the perceptions of
youths about the risks of drug abuse.
(9) Diverting individuals with substance use disorders from
criminal justice systems into community-based treatment can
save billions of dollars and prevent sizeable numbers of
crimes, arrests, and re-incarcerations over the course of those
individuals' lives.
(10) According to the Drug Enforcement Agency, more than
1,700 tons of expired, unwanted prescription medications have
been collected during the past 3\1/2\ years, following the
enactment of the Secure and Responsible Drug Disposal Act of
2010 (Public Law 111-273; 124 Stat. 2858).
(11) Research shows that combining treatment medications
with behavioral therapy is the best way to facilitate success
for most patients. Treatment approaches must be tailored to
address the drug abuse patterns and drug-related medical,
psychiatric, and social problems of each individual. Different
types of medications may be useful at different stages of
treatment or recovery to help a patient stop using drugs, stay
in treatment, and avoid relapse.
(12) Research indicates that combating the opioid crisis,
including abuse of prescription painkillers and, increasingly,
heroin, requires a multi-pronged approach that involves
reducing drug diversion, expanding delivery of existing
treatments (including medication assisted treatments),
expanding access to overdose medications and interventions, and
the development of new medications for pain that can augment
the existing treatment arsenal.
(13) Individuals with mental illness, especially severe
mental illness, are at considerably higher risk for substance
abuse than the general population, and the presence of a mental
illness complicates recovery from substance abuse.
SEC. 3. DEFINITIONS.
In this Act--
(1) the term ``medication assisted treatment'' means the
use, for problems relating to heroin and other opioids, of
medications approved by the Food and Drug Administration in
combination with counseling and behavioral therapies;
(2) the term ``ONDCP Recovery Branch'' means the Recovery
Branch of the Office of National Drug Control Policy;
(3) the term ``opioid'' means any drug having an addiction-
forming or addiction-sustaining liability similar to morphine
or being capable of conversion into a drug having such
addiction-forming or addiction-sustaining liability; and
(4) the term ``State'' means any State of the United
States, the District of Columbia, the Commonwealth of Puerto
Rico, and any territory or possession of the United States.
TITLE I--PREVENTION AND EDUCATION
SEC. 101. DEVELOPMENT OF BEST PRESCRIBING PRACTICES.
(a) Inter-Agency Task Force.--Not later than 120 days after the
date of enactment of this Act, the Secretary of Health and Human
Services (referred to in this section as the ``Secretary''), in
cooperation with the Secretary of Veterans Affairs, the Secretary of
Defense, and the Administrator of the Drug Enforcement Administration,
shall convene a Pain Management Best Practices Inter-Agency Task Force
(referred to in this section as the ``task force'').
(b) Membership.--The task force shall be comprised of--
(1) representatives of--
(A) the Department of Health and Human Services;
(B) the Department of Veterans Affairs;
(C) the Department of Defense;
(D) the Drug Enforcement Administration;
(E) the Centers for Disease Control and Prevention;
(F) the Institute of Medicine; and
(G) the Office of National Drug Control Policy;
(2) the Director of the National Institutes of Health;
(3) physicians, dentists, and non-physician prescribers;
(4) pharmacists;
(5) experts in the fields of pain research and addiction
research;
(6) representatives of--
(A) pain management professional organizations;
(B) the mental health treatment community;
(C) the addiction treatment community;
(D) pain advocacy groups; and
(E) groups with expertise around overdose reversal;
and
(7) other stakeholders, as the Secretary determines
appropriate.
(c) Duties.--The task force shall--
(1) not later than 180 days after the date on which the
task force is convened under subsection (a), develop best
practices for pain management (including chronic and acute
pain) and prescribing pain medication, taking into
consideration--
(A) existing pain management research;
(B) recommendations from relevant conferences;
(C) ongoing efforts at the State and local levels
and by medical professional organizations to develop
improved pain management strategies; and
(D) the management of high-risk populations, other
than populations who suffer pain, who--
(i) may use or be prescribed
benzodiazepines, alcohol, and diverted opioids;
or
(ii) receive opioids in the course of
medical care;
(2) solicit and take into consideration public comment on
the practices developed under paragraph (1), amending such best
practices if appropriate; and
(3) develop a strategy for disseminating information about
the best practices developed under paragraphs (1) and (2) to
prescribers, health professionals, pharmacists, State medical
boards, and other parties, as the Secretary determines
appropriate.
(d) Limitation.--The task force shall not have rulemaking
authority.
(e) Report.--Not later than 270 days after the date on which the
task force is convened under subsection (a), the task force shall
submit to Congress a report that includes--
(1) the strategy for disseminating best practices developed
under subsection (c);
(2) the results of a feasibility study on linking best
practices developed under subsection (c) to receiving and
renewing registrations under section 303(f) of the Controlled
Substances Act (21 U.S.C. 823(f)); and
(3) recommendations on how to apply best practices
developed under subsection (c) to improve prescribing practices
at medical facilities, including medical facilities of the
Veterans Health Administration.
SEC. 102. NATIONAL EDUCATION CAMPAIGN.
Title I of the Omnibus Crime Control and Safe Streets Act of 1968
(42 U.S.C. 3711 et seq.) is amended by adding at the end the following:
``PART MM--DRUG TREATMENT GRANTS
``SEC. 3031. DEFINITIONS.
``In this part--
``(1) the term `civil liability protection law' means a
State law that protects from civil liability individuals who
give aid on a voluntary basis in an emergency to individuals
who are ill, in peril, or otherwise incapacitated;
``(2) the term `medication assisted treatment' means the
use, for problems relating to heroin and other opioids, of
medications approved by the Food and Drug Administration in
combination with counseling and behavioral therapies;
``(3) the term `opioid' means any drug having an addiction-
forming or addiction-sustaining liability similar to morphine
or being capable of conversion into a drug having such
addiction-forming or addiction-sustaining liability; and
``(4) the term `Single State Authority for Substance Abuse'
has the meaning given the term in section 201(e) of the Second
Chance Act of 2007 (42 U.S.C. 17521(e)).
``SEC. 3032. NATIONAL EDUCATION CAMPAIGN.
``(a) Definitions.--In this section--
``(1) the term `eligible entity' means a State, unit of
local government, or nonprofit organization; and
``(2) the terms `elementary school' and `secondary school'
have the meaning given those terms in section 9101 of the
Elementary and Secondary Education Act of 1965 (20 U.S.C.
7801).
``(b) Program Authorized.--The Attorney General, in coordination
with the Secretary of Health and Human Services, the Director of the
Office of National Drug Control Policy, the Secretary of Education, the
Administrator of the Substance Abuse and Mental Health Services
Administration, and the Director of the Centers for Disease Control and
Prevention, may make grants to eligible entities to expand educational
efforts to prevent abuse of opioids, heroin, and other substances of
abuse, understand addiction as a chronic disease, and promote treatment
and recovery, including--
``(1) parent and caretaker-focused prevention efforts,
including--
``(A) the development of research-based community
education online and social media materials with an
accompanying toolkit that can be disseminated to
communities to educate parents and other caretakers of
teens on--
``(i) how to educate teens about opioid and
heroin abuse;
``(ii) how to intervene if a parent thinks
or knows their teen is abusing opioids or
heroin;
``(iii) signs of opioid or heroin overdose;
and
``(iv) the use of naloxone to prevent death
from opioid or heroin overdose;
``(B) the development of detailed digital and print
educational materials to accompany the online and
social media materials and toolkit described in
subparagraph (A);
``(C) the development and dissemination of public
service announcements to--
``(i) raise awareness of heroin and opioid
abuse among parents and other caretakers;
``(ii) motivate parents and other
caretakers to visit online educational
materials on heroin and opioid abuse; and
``(iii) provide information for public
health agencies and nonprofit organizations
that provide overdose reversal and prevention
services and community referrals; and
``(D) the dissemination of educational materials to
the media through--
``(i) a town hall or panel discussion with
experts;
``(ii) a press release;
``(iii) an online news release;
``(iv) a media tour; and
``(v) sharable infographics;
``(2) prevention efforts focused on teenagers, young
adults, and college students, including the development of--
``(A) a national digital campaign;
``(B) a community education toolkit for use by
community coalitions;
``(C) evidence-based resources for prevention and
treatment professionals targeting individuals who are
between 18 and 24 years of age, including college
students; and
``(D) technical support centers for prevention and
treatment professionals, elementary and secondary
school-based professionals, and college-based
professionals, including recovery staff, to implement
and sustain evidence-based educational and prevention
programs;
``(3) campaigns to inform individuals about available
resources to aid in recovery from substance use disorder;
``(4) encouragement of individuals in or seeking recovery
from substance use disorder to enter the health care system; or
``(5) adult-focused awareness efforts, including efforts
focused on older adults, relating to prescription medication
disposal, opioid and heroin abuse, signs of overdose, and the
use of naloxone for reversal.
``(c) Application.--
``(1) In general.--An eligible entity desiring a grant
under this section shall submit an application to the Attorney
General--
``(A) that meets the criteria under paragraph (2);
and
``(B) at such time, in such manner, and accompanied
by such information as the Attorney General may
require.
``(2) Criteria.--An eligible entity, in submitting an
application under paragraph (1), shall--
``(A) describe the evidence-based methodology and
outcome measurements that will be used to evaluate the
program funded with a grant under this section;
``(B) specifically explain how the measurements
described in subparagraph (A) will provide valid
measures of the impact of the program described in
subparagraph (A);
``(C) describe how the program described in
subparagraph (A) could be broadly replicated if
demonstrated to be effective;
``(D) demonstrate that all planned services will be
research-informed, which may include evidence-based
practices documented in--
``(i) the report of the Institute of
Medicine entitled `Preventing Mental,
Emotional, and Behavioral Disorders Among Young
People'; or
``(ii) the National Registry of Effective
Programs and Practices (commonly referred to as
`NREPP') of the Substance Abuse and Mental
Health Administration; and
``(E) demonstrate that the eligible entity will
effectively integrate and sustain the program described
in subparagraph (A) into curriculum or community
outreach efforts.
``(d) Use of Funds.--A grantee shall use a grant received under
this section for expenses of educational efforts to--
``(1) prevent abuse of opioids, heroin, alcohol, and other
drugs; or
``(2) promote treatment and recovery.
``(e) Duration.--The Attorney General shall award grants under this
section for a period not to exceed 2 years.
``(f) Priority Consideration With Respect to States.--In awarding
grants to States under this section, the Attorney General shall give
priority to a State that provides civil liability protection for first
responders, health professionals, and family members administering
naloxone to counteract opioid overdoses by--
``(1) enacting legislation that provides such civil
liability protection; or
``(2) providing a certification by the attorney general of
the State that the attorney general has--
``(A) reviewed any applicable civil liability
protection law to determine the applicability of the
law with respect to first responders, health care
professionals, family members, and other individuals
who may administer naloxone to individuals reasonably
believed to be suffering from opioid overdose; and
``(B) concluded that the law described in
subparagraph (A) provides adequate civil liability
protection applicable to such persons.
``(g) Information Sharing.--The Office of the Attorney General, in
coordination with the Substance Abuse and Mental Health Services
Administration and the Department of Education, shall review existing
evidence-based programs and emerging practices and programs and provide
information to schools and communities about such programs and
practices.
``(h) Authorization of Appropriations.--There are authorized to be
appropriated to carry out this section $2,500,000 for each of fiscal
years 2016 through 2020.''.
SEC. 103. COMMUNITY-BASED COALITION ENHANCEMENT GRANTS TO ADDRESS LOCAL
DRUG CRISES.
Part MM of title I of the Omnibus Crime Control and Safe Streets
Act of 1968, as added by section 102, is amended by adding at the end
the following:
``SEC. 3033. COMMUNITY-BASED COALITION ENHANCEMENT GRANTS TO ADDRESS
LOCAL DRUG CRISES.
``(a) Definitions.--In this section--
``(1) the term `Drug-Free Communities Act of 1997' means
chapter 2 of the National Narcotics Leadership Act of 1988 (21
U.S.C. 1521 et seq.);
``(2) the term `eligible entity' means an organization
that--
``(A) on or before the date of submitting an
application for a grant under this section, receives or
has received a grant under the Drug-Free Communities
Act of 1997; and
``(B) has documented, using local data, rates of
abuse of opioids at levels that are--
``(i) significantly higher than the
national average as determined by the Attorney
General (including appropriate consideration of
the Monitoring the Future Survey published by
the National Institute on Drug Abuse and the
National Survey on Drug Use and Health by the
Substance Abuse and Mental Health Service
Administration); or
``(ii) higher than the national average, as
determined by the Attorney General (including
appropriate consideration of the surveys
described in clause (i)), over a sustained
period of time; and
``(3) the term `local drug crisis' means, with respect to
the area served by an eligible entity--
``(A) a sudden increase in the abuse of opioids, as
documented by local data; or
``(B) the abuse of prescription medications,
specifically opioids, that is significantly higher than
the national average, over a sustained period of time,
as documented by local data.
``(b) Program Authorized.--The Attorney General, in coordination
with the Director, may make grants to eligible entities to implement
comprehensive community-wide strategies that address local drug crises
within the area served by the eligible entity.
``(c) Application.--
``(1) In general.--An eligible entity desiring a grant
under this section shall submit an application to the Attorney
General at such time, in such manner, and accompanied by such
information as the Attorney General may require.
``(2) Criteria.--As part of an application for a grant
under this section, the Attorney General shall require an
eligible entity to submit a detailed, comprehensive, multi-
sector plan for addressing the local drug crisis within the
area served by the eligible entity.
``(d) Use of Funds.--An eligible entity shall use a grant received
under this section--
``(1) for programs designed to implement comprehensive
community-wide prevention strategies to address local drug
crisis in the area served by the eligible entity, in accordance
with the plan submitted under subsection (c)(2); and
``(2) to obtain specialized training and technical
assistance from the organization funded under section 4 of
Public Law 107-82 (21 U.S.C. 1521 note).
``(e) Grant Amounts and Duration.--
``(1) Amounts.--The Attorney General may not award a grant
under this section for a fiscal year in an amount that
exceeds--
``(A) the amount of non-Federal funds raised by the
eligible entity, including in-kind contributions, for
that fiscal year; or
``(B) $75,000.
``(2) Duration.--The Attorney General shall award grants
under this section for a period not to exceed 4 years.
``(f) Supplement Not Supplant.--An eligible entity shall use
Federal funds received under this section only to supplement the funds
that would, in the absence of those Federal funds, be made available
from other Federal and non-Federal sources for the activities described
in this section, and not to supplant those funds.
``(g) Evaluation.--A grant under this section shall be subject to
the same evaluation requirements and procedures as the evaluation
requirements and procedures imposed on the recipient of a grant under
the Drug-Free Communities Act of 1997.
``(h) Limitation on Administrative Expenses.--Not more than 8
percent of the amounts made available pursuant to subsection (i) for a
fiscal year may be used by the Attorney General to pay for
administrative expenses.
``(i) Authorization of Appropriations.--There are authorized to be
appropriated to carry out this section $5,000,000 for each of fiscal
years 2016 through 2020.''.
TITLE II--LAW ENFORCEMENT AND TREATMENT
SEC. 201. TREATMENT ALTERNATIVE TO INCARCERATION PROGRAMS.
Part MM of the Omnibus Crime Control and Safe Streets Act of 1968,
as amended by section 103, is amended by adding at the end the
following:
``SEC. 3034. TREATMENT ALTERNATIVE TO INCARCERATION PROGRAMS.
``(a) Definitions.--In this section--
``(1) the term `eligible entity' means a State, unit of
local government, Indian tribe, or nonprofit organization; and
``(2) the term `eligible participant' means an individual
who--
``(A) comes into contact with the juvenile justice
system or criminal justice system or is arrested or
charged with an offense;
``(B) has a history of or a current--
``(i) substance use disorder;
``(ii) mental illness; or
``(iii) co-occurring mental illness and
substance use disorders; and
``(C) has been approved for participation in a
program funded under this section by, as applicable
depending on the stage of the criminal justice process,
the relevant law enforcement agency or prosecuting
attorney, defense attorney, probation or corrections
official, judge, or representative from the relevant
mental health or substance abuse agency.
``(b) Program Authorized.--The Attorney General may make grants to
eligible entities to develop, implement, or expand a treatment
alternative to incarceration program for eligible participants,
including--
``(1) pre-booking treatment alternative to incarceration
programs, including--
``(A) law enforcement training on substance use
disorders, mental illness, and co-occurring mental
illness and substance use disorders;
``(B) receiving centers as alternatives to
incarceration of eligible participants;
``(C) specialized response units for calls related
to substance use disorders, mental illness, and co-
occurring mental illness and substance use disorders;
and
``(D) other arrest and pre-booking treatment
alternative to incarceration models; and
``(2) post-booking treatment alternative to incarceration
programs, including--
``(A) specialized clinical case management;
``(B) pre-trial services related to substances use
disorders, mental illness, and co-occurring mental
illness and substance use disorders;
``(C) prosecutor and defender based programs;
``(D) specialized probation;
``(E) programs utilizing the American Society of
Addiction Medicine patient placement criteria;
``(F) treatment and rehabilitation programs and
recovery support services; and
``(G) drug courts, DWI courts, and veterans
treatment courts.
``(c) Application.--
``(1) In general.--An eligible entity desiring a grant
under this section shall submit an application to the Attorney
General--
``(A) that meets the criteria under paragraph (2);
and
``(B) at such time, in such manner, and accompanied
by such information as the Attorney General may
require.
``(2) Criteria.--An eligible entity, in submitting an
application under paragraph (1), shall--
``(A) provide extensive evidence of collaboration
with State and local government agencies overseeing
health, community corrections, courts, prosecution,
substance abuse, mental health, victims services, and
employment services, and with local law enforcement
agencies;
``(B) demonstrate consultation with the Single
State Authority for Substance Abuse;
``(C) demonstrate that evidence-based treatment
practices will be utilized; and
``(D) demonstrate that evidenced-based screening
and assessment tools will be utilized to place
participants in the treatment alternative to
incarceration program.
``(d) Requirements.--Each eligible entity awarded a grant for a
treatment alternative to incarceration program under this section
shall--
``(1) determine the terms and conditions of participation
in the program by eligible participants, taking into
consideration the collateral consequences of an arrest,
prosecution, or criminal conviction;
``(2) ensure that each substance abuse and mental health
treatment component is licensed and qualified by the relevant
jurisdiction;
``(3) for programs described in subsection (b)(2), organize
an enforcement unit comprised of appropriately trained law
enforcement professionals under the supervision of the State,
tribal, or local criminal justice agency involved, the duties
of which shall include--
``(A) the verification of addresses and other
contacts of each eligible participant who participates
or desires to participate in the program; and
``(B) if necessary, the location, apprehension,
arrest, and return to court of an eligible participant
in the program who has absconded from the facility of a
treatment provider or has otherwise violated the terms
and conditions of the program, consistent with Federal
and State confidentiality requirements;
``(4) notify the relevant criminal justice entity if any
eligible participant in the program absconds from the facility
of the treatment provider or otherwise violates the terms and
conditions of the program, consistent with Federal and State
confidentiality requirements;
``(5) submit periodic reports on the progress of treatment
or other measured outcomes from participation in the program of
each eligible offender participating in the program to the
relevant State, tribal, or local criminal justice agency;
``(6) describe the evidence-based methodology and outcome
measurements that will be used to evaluate the program, and
specifically explain how such measurements will provide valid
measures of the impact of the program; and
``(7) describe how the program could be broadly replicated
if demonstrated to be effective.
``(e) Use of Funds.--An eligible entity shall use a grant received
under this section for expenses of a treatment alternative to
incarceration program, including--
``(1) salaries, personnel costs, equipment costs, and other
costs directly related to the operation of the program,
including the enforcement unit;
``(2) payments for treatment providers that are approved by
the relevant State or tribal jurisdiction and licensed, if
necessary, to provide needed treatment to eligible offenders
participating in the program, including medication assisted
treatment, aftercare supervision, vocational training,
education, and job placement; and
``(3) payments to public and nonprofit private entities
that are approved by the State or tribal jurisdiction and
licensed, if necessary, to provide alcohol and drug addiction
treatment and mental health treatment to eligible offenders
participating in the program.
``(f) Supplement Not Supplant.--An eligible entity shall use
Federal funds received under this section only to supplement the funds
that would, in the absence of those Federal funds, be made available
from other Federal and non-Federal sources for the activities described
in this section, and not to supplant those funds.
``(g) Geographic Distribution.--The Attorney General shall ensure
that, to the extent practicable, the geographical distribution of
grants under this section is equitable and includes a grant to an
eligible entity in--
``(1) each State;
``(2) rural, suburban, and urban areas; and
``(3) tribal jurisdictions.
``(h) Priority Consideration With Respect to States.--In awarding
grants to States under this section, the Attorney General shall give
priority to a State that provides civil liability protection for first
responders, health professionals, and family members administering
naloxone to counteract opioid overdoses by--
``(1) enacting legislation that provides such civil
liability protection; or
``(2) providing a certification by the attorney general of
the State that the attorney general has--
``(A) reviewed any applicable civil liability
protection law to determine the applicability of the
law with respect to first responders, health care
professionals, family members, and other individuals
who may administer naloxone to individuals reasonably
believed to be suffering from opioid overdose; and
``(B) concluded that the law described in
subparagraph (A) provides adequate civil liability
protection applicable to such persons.
``(i) Reports and Evaluations.--
``(1) In general.--Each fiscal year, each recipient of a
grant under this section during that fiscal year shall submit
to the Attorney General a report on the outcomes of activities
carried out using that grant in such form, containing such
information, and on such dates as the Attorney General shall
specify.
``(2) Contents.--A report submitted under paragraph (1)
shall--
``(A) describe best practices for treatment
alternatives; and
``(B) identify training requirements for law
enforcement officers who participate in treatment
alternative to incarceration programs.
``(j) Authorization of Appropriations.--There are authorized to be
appropriated to carry out this section $5,000,000 for each of fiscal
years 2016 through 2020.''.
SEC. 202. LAW ENFORCEMENT NALOXONE TRAINING AND IMPLEMENTATION
DEMONSTRATION.
Part MM of the Omnibus Crime Control and Safe Streets Act of 1968,
as amended by section 201, is amended by adding at the end the
following:
``SEC. 3035. LAW ENFORCEMENT NALOXONE TRAINING AND IMPLEMENTATION
DEMONSTRATION.
``(a) Definition.--In this section, the term `eligible entity'
means a State, local, or tribal law enforcement agency.
``(b) Program Authorized.--The Attorney General, in coordination
with the Secretary of Health and Human Services and the Director of the
Office of National Drug Control Policy, may make grants to eligible
entities to create a demonstration law enforcement program to prevent
opioid and heroin overdose death.
``(c) Application.--
``(1) In general.--An eligible entity desiring a grant
under this section shall submit an application to the Attorney
General--
``(A) that meets the criteria under paragraph (2);
and
``(B) at such time, in such manner, and accompanied
by such information as the Attorney General may
require.
``(2) Criteria.--An eligible entity, in submitting an
application under paragraph (1), shall--
``(A) describe the evidence-based methodology and
outcome measurements that will be used to evaluate the
program funded with a grant under this section, and
specifically explain how such measurements will provide
valid measures of the impact of the program;
``(B) describe how the program could be broadly
replicated if demonstrated to be effective;
``(C) identify the governmental and community
agencies that the program will coordinate; and
``(D) describe how law enforcement agencies will
coordinate with their corresponding State substance
abuse and mental health agencies to identify protocols
and resources that are available to victims and
families, including information on treatment and
recovery resources.
``(d) Use of Funds.--An eligible entity shall use a grant received
under this section to--
``(1) make naloxone available to be carried and
administered by law enforcement officers;
``(2) train and provide resources for law enforcement
officers on carrying and administering naloxone for the
prevention of opioid and heroin overdose death; and
``(3) establish processes, protocols, and mechanisms for
referral to treatment.
``(e) Grant Amounts and Duration.--
``(1) Maximum amount.--The Attorney General may not award a
grant under this section in an amount that exceeds $500,000.
``(2) Duration.--The Attorney General shall award grants
under this section for a period not to exceed 2 years.
``(f) Technical Assistance Grants.--The Attorney General shall make
a grant for the purpose of providing technical assistance and training
on the use of naloxone to reverse overdose deaths and mechanisms for
referral to treatment for an eligible entity receiving a grant under
this section.
``(g) Evaluation.--The Attorney General shall conduct an evaluation
of grants made under this section to determine--
``(1) the number of officers equipped with naloxone for the
prevention of fatal opioid and heroin overdose;
``(2) the number of opioid and heroin overdoses reversed by
officers receiving training and supplies of naloxone through a
grant received under this section;
``(3) the number of calls for service related to opioid and
heroin overdose;
``(4) the extent to which overdose victims and families
receive information about treatment services and available data
describing treatment admissions; and
``(5) the research, training, and naloxone supply needs of
law enforcement and first responder agencies, including those
agencies that are not receiving grants under this section.
``(h) Authorization of Appropriations.--There are authorized to be
appropriated to carry out this section $5,000,000 for each of fiscal
years 2016 through 2020.''.
SEC. 203. PRESCRIPTION DRUG TAKE BACK EXPANSION.
Part MM of the Omnibus Crime Control and Safe Streets Act of 1968,
as amended by section 202, is amended by adding at the end the
following:
``SEC. 3036. PRESCRIPTION DRUG TAKE BACK EXPANSION.
``(a) Definition.--In this section, the term `eligible entity'
means--
``(1) a State, local, or tribal law enforcement agency;
``(2) a manufacturer, distributor, or reverse distributor
of prescription medications;
``(3) a retail pharmacy;
``(4) a registered narcotic treatment program;
``(5) a hospital or clinic with an on-site pharmacy;
``(6) an eligible long-term care facility; or
``(7) any other entity authorized by the Drug Enforcement
Administration to dispose of prescription medications.
``(b) Program Authorized.--The Attorney General, in coordination
with the Administrator of the Drug Enforcement Administration, the
Secretary of Health and Human Services, and the Director of the Office
of National Drug Control Policy, may make grants to eligible entities
to expand or make available disposal sites for unwanted prescription
medications.
``(c) Application.--
``(1) In general.--An eligible entity desiring a grant
under this section shall submit an application to the Attorney
General--
``(A) that meets the criteria under paragraph (2);
and
``(B) at such time, in such manner, and accompanied
by such information as the Attorney General may
require.
``(2) Criteria.--An eligible entity, in submitting an
application under paragraph (1), shall--
``(A) describe the evidence-based methodology and
outcome measurements that will be used to evaluate the
program funded with a grant under this section, and
specifically explain how such measurements will provide
valid measures of the impact of the program;
``(B) describe how the program could be broadly
replicated if demonstrated to be effective; and
``(C) identify the governmental and community
agencies that will coordinate the program.
``(d) Use of Funds.--An eligible entity shall use a grant received
under this section for--
``(1) expenses of a prescription drug disposal site,
including materials and resources;
``(2) implementing disposal procedures and processes;
``(3) implementing community education strategies,
including community education materials and resources;
``(4) replicating a prescription drug take back initiative
throughout multiple jurisdictions; and
``(5) training of law enforcement officers and other
community participants.
``(e) Grant Amounts and Duration.--
``(1) Maximum amount.--The Attorney General may not award a
grant under this section in an amount that exceeds $250,000.
``(2) Duration.--The Attorney General shall award grants
under this section for a period not to exceed 2 years.
``(f) Technical Assistance Grant.--The Attorney General shall make
a grant to a national nonprofit organization to provide technical
assistance and training for an eligible entity receiving a grant under
this section.
``(g) Evaluation.--
``(1) In general.--The Attorney General shall make a grant
for evaluation of the performance of each eligible entity
receiving a grant under this section.
``(2) Reports.--Each fiscal year, the recipient of a grant
under this subsection shall submit to the Attorney General a
report that evaluates--
``(A) the effectiveness of the prescription drug
take back program of each eligible entity receiving a
grant under this section; and
``(B) the effect of disposal efforts on drug
circulation.
``(h) Authorization of Appropriations.--There are authorized to be
appropriated to carry out this section $2,500,000 for each of fiscal
years 2016 through 2020.''.
TITLE III--TREATMENT AND RECOVERY
SEC. 301. EVIDENCE-BASED OPIOID AND HEROIN TREATMENT AND INTERVENTIONS
DEMONSTRATION.
Subpart 1 of part B of title V of the Public Health Service Act (42
U.S.C. 290bb et seq.) is amended--
(1) by redesignating section 514 (42 U.S.C. 290bb-9), as
added by section 3632 of the Methamphetamine Anti-Proliferation
Act of 2000 (Public Law 106-310; 114 Stat. 1236), as section
514B; and
(2) by adding at the end the following:
``SEC. 514C. EVIDENCE-BASED OPIOID AND HEROIN TREATMENT AND
INTERVENTIONS DEMONSTRATION.
``(a) Grants.--
``(1) Authority to make grants.--The Director of the Center
for Substance Abuse Treatment (referred to in this section as
the `Director') may award grants to State substance abuse
agencies, units of local government, nonprofit organizations,
and Indian tribes or tribal organizations (as defined in
section 4 of the Indian Health Care Improvement Act (25 U.S.C.
1603)) that have a high rate, or have had a rapid increase, in
the use of heroin or other opioids, in order to permit such
entities to expand activities, including an expansion in the
availability of medication assisted treatment, with respect to
the treatment of addiction in the specific geographical areas
of such entities where there is a rate or rapid increase in the
use of heroin or other opioids.
``(2) Recipients.--The entities receiving grants under
paragraph (1) shall be selected by the Director.
``(3) Nature of activities.--The grant funds awarded under
paragraph (1) shall be used for activities that are based on
reliable scientific evidence of efficacy in the treatment of
problems related to heroin or other opioids.
``(b) Geographic Distribution.--The Director shall ensure that
grants awarded under subsection (a) are distributed equitably among the
various regions of the Nation and among rural, urban, and suburban
areas that are affected by the use of heroin or other opioids.
``(c) Additional Activities.--The Director shall--
``(1) evaluate the activities supported by grants awarded
under subsection (a);
``(2) disseminate widely such significant information
derived from the evaluation as the Director considers
appropriate;
``(3) provide States, Indian tribes and tribal
organizations, and providers with technical assistance in
connection with the provision of treatment of problems related
to heroin and other opioids; and
``(4) fund only those applications that specifically
support recovery services as a critical component of the grant
program.
``(d) Definition.--The term `medication assisted treatment' means
the use, for problems relating to heroin and other opioids, of
medications approved by the Food and Drug Administration in combination
with counseling and behavioral therapies.
``(e) Authorization of Appropriations.--
``(1) In general.--There are authorized to be appropriated
to carry out this section $12,000,000 for fiscal year 2016 and
such sums as may be necessary for each of fiscal years 2016
through 2020.
``(2) Use of certain funds.--Of the funds appropriated to
carry out this section in any fiscal year, the lesser of 5
percent of such funds or $1,000,000 shall be available to the
Director for purposes of carrying out subsection (c).''.
SEC. 302. CRIMINAL JUSTICE MEDICATION ASSISTED TREATMENT AND
INTERVENTIONS DEMONSTRATION.
Part MM of the Omnibus Crime Control and Safe Streets Act of 1968,
as amended by section 203, is amended by adding at the end the
following:
``SEC. 3037. CRIMINAL JUSTICE MEDICATION ASSISTED TREATMENT AND
INTERVENTIONS DEMONSTRATION.
``(a) Definitions.--In this section--
``(1) the term `criminal justice agency' means a State,
local, or tribal--
``(A) court;
``(B) prison;
``(C) jail; or
``(D) other agency that performs the administration
of criminal justice, including prosecution, pretrial
services, and community supervision; and
``(2) the term `eligible entity' means a State, unit of
local government, or Indian tribe.
``(b) Program Authorized.--The Attorney General, in coordination
with the Secretary of Health and Human Services and the Director of the
Office of National Drug Control Policy, may make grants to eligible
entities to implement medication assisted treatment programs through
criminal justice agencies.
``(c) Application.--
``(1) In general.--An eligible entity desiring a grant
under this section shall submit an application to the Attorney
General--
``(A) that meets the criteria under paragraph (2);
and
``(B) at such time, in such manner, and accompanied
by such information as the Attorney General may
require.
``(2) Criteria.--An eligible entity, in submitting an
application under paragraph (1), shall--
``(A) certify that each medication assisted
treatment program funded with a grant under this
section has been developed in consultation with the
Single State Authority for Substance Abuse; and
``(B) describe how data will be collected and
analyzed to determine the effectiveness of the program
described in subparagraph (A).
``(d) Use of Funds.--An eligible entity shall use a grant received
under this section for expenses of--
``(1) a medication assisted treatment program, including
the expenses of prescribing medications recognized by the Food
and Drug Administration for opioid treatment in conjunction
with psychological and behavioral therapy;
``(2) training criminal justice agency personnel and
treatment providers on medication assisted treatment;
``(3) cross-training personnel providing behavioral health
and health services, administration of medicines, and other
administrative expenses, including required reports; and
``(4) the provision of recovery coaches who are responsible
for providing mentorship and transition plans to individuals
reentering society following incarceration or alternatives to
incarceration.
``(e) Grant Amounts and Duration.--
``(1) Maximum amount.--The Attorney General may not award a
grant under this section in an amount that exceeds $750,000.
``(2) Duration.--The Attorney General shall award grants
under this section for a period not to exceed 2 years.
``(f) Priority Consideration With Respect to States.--In awarding
grants to States under this section, the Attorney General shall give
priority to a State that provides civil liability protection for first
responders, health professionals, and family members administering
naloxone to counteract opioid overdoses by--
``(1) enacting legislation that provides such civil
liability protection; or
``(2) providing a certification by the attorney general of
the State that the attorney general has--
``(A) reviewed any applicable civil liability
protection law to determine the applicability of the
law with respect to first responders, health care
professionals, family members, and other individuals
who may administer naloxone to individuals reasonably
believed to be suffering from opioid overdose; and
``(B) concluded that the law described in
subparagraph (A) provides adequate civil liability
protection applicable to such persons.
``(g) Technical Assistance.--The Attorney General, in coordination
with the Director of the National Institute on Drug Abuse and the
Secretary of Health and Human Services, shall provide technical
assistance and training for an eligible entity receiving a grant under
this section.
``(h) Reports.--
``(1) In general.--An eligible entity receiving a grant
under this subsection shall submit a report to the Attorney
General on the outcomes of each grant received under this
section for individuals receiving medication assisted
treatment, based on--
``(A) the recidivism of the individuals;
``(B) the treatment outcomes of the individuals,
including maintaining abstinence from illegal,
unauthorized, and unprescribed or undispensed opioids
and heroin;
``(C) a comparison of the cost of providing
medication assisted treatment to the cost of
incarceration or other participation in the criminal
justice system;
``(D) the housing status of the individuals; and
``(E) the employment status of the individuals.
``(2) Contents and timing.--Each report described in
paragraph (1) shall be submitted annually in such form,
containing such information, and on such dates as the Attorney
General shall specify.
``(i) Authorization of Appropriations.--There are authorized to be
appropriated to carry out this section $5,000,000 for each of fiscal
years 2016 through 2020.''.
SEC. 303. NATIONAL YOUTH RECOVERY INITIATIVE.
(a) Definitions.--In this section:
(1) Eligible entity.--The term ``eligible entity'' means--
(A) a high school that has been accredited as a
recovery high school by the Association of Recovery
Schools;
(B) an accredited high school that is seeking to
establish or expand recovery support services;
(C) an institution of higher education;
(D) a recovery program at a nonprofit collegiate
institution; or
(E) a nonprofit organization.
(2) Institution of higher education.--The term
``institution of higher education'' has the meaning given the
term in section 101 of the Higher Education Act of 1965 (20
U.S.C. 1001).
(3) Recovery program.--The term ``recovery program''--
(A) means a program to help individuals who are
recovering from substance use disorders to initiate,
stabilize, and maintain healthy and productive lives in
the community; and
(B) includes peer-to-peer support and communal
activities to build recovery skills and supportive
social networks.
(b) Grants Authorized.--The ONDCP Recovery Branch, in consultation
with the Secretary of Education, may award grants to eligible entities
to enable the entities to--
(1) provide substance use recovery support services to
young people in high school and enrolled in institutions of
higher education;
(2) help build communities of support for young people in
recovery through a spectrum of activities such as counseling
and healthy and wellness-oriented social activities; and
(3) encourage initiatives designed to help young people
achieve and sustain recovery from substance use disorders.
(c) Use of Funds.--Grants awarded under subsection (b) may be used
for activities to develop, support, and maintain youth recovery support
services, including--
(1) the development and maintenance of a dedicated physical
space for recovery programs;
(2) dedicated staff for the provision of recovery programs;
(3) healthy and wellness-oriented social activities and
community engagement;
(4) establishment of recovery high schools;
(5) coordination of recovery programs with--
(A) substance use disorder treatment programs and
systems;
(B) providers of mental health services;
(C) primary care providers;
(D) the criminal justice system, including the
juvenile justice system;
(E) employers;
(F) housing services;
(G) child welfare services;
(H) institutions of secondary higher education and
institutions of higher education; and
(I) other programs or services related to the
welfare of an individual in recovery from a substance
use disorder;
(6) the development of peer-to-peer support programs or
services; and
(7) additional activities that help youths and young adults
to achieve recovery from substance use disorders.
(d) Resource Center.--The ONDCP Recovery Branch shall establish a
resource center to provide technical support to recipients of grants
under this section.
(e) Authorization of Appropriations.--There are authorized to be
appropriated to carry out this section $3,000,000 for fiscal year 2016
and each of the 5 succeeding fiscal years.
SEC. 304. BUILDING COMMUNITIES OF RECOVERY.
(a) Definition.--In this section, the term ``recovery community
organization'' means an independent nonprofit organization that--
(1) mobilizes resources within and outside of the recovery
community to increase the prevalence and quality of long-term
recovery from substance use disorders; and
(2) is wholly or principally governed by people in recovery
for substance use disorders who reflect the community served.
(b) Grants Authorized.--The ONDCP Recovery Branch, in consultation
with the Substance Abuse and Mental Health Services Administration, may
award grants to recovery community organizations to enable such
organizations to develop, expand, and enhance recovery services.
(c) Maximum Grant Amount.--The ONDCP Recovery Branch may not award
a grant under this section in an amount that exceeds $200,000.
(d) Federal Share.--The Federal share of the costs of a program
funded by a grant under this section may not exceed 50 percent.
(e) Use of Funds.--Grants awarded under subsection (b)--
(1) shall be used to develop, expand, and enhance community
and statewide recovery support services; and
(2) may be used to--
(A) advocate for individuals in recovery from
substance use disorders;
(B) build connections between recovery networks,
between recovery community organizations, and with
other recovery support services, including--
(i) substance use disorder treatment
programs and systems;
(ii) providers of mental health services;
(iii) primary care providers;
(iv) the criminal justice system;
(v) employers;
(vi) housing services;
(vii) child welfare agencies; and
(viii) other recovery support services that
facilitate recovery from substance use
disorders;
(C) reduce the stigma associated with substance use
disorders;
(D) conduct public education and outreach on issues
relating to substance use disorders and recovery,
including--
(i) how to identify the signs of addiction;
(ii) the resources that are available for
individuals struggling with addiction;
(iii) the resources that are available to
help support individuals in recovery; and
(iv) information on the medical
consequences of substance use disorders,
including neonatal abstinence syndrome and
potential infection with human immunodeficiency
virus and viral hepatitis; and
(E) carry out other activities that strengthen the
network of community support for individuals in
recovery.
(f) Resource Center.--The ONDCP Recovery Branch shall establish a
resource center to provide technical assistance to recipients of grants
under this section and to provide information to individuals seeking to
support people in recovery from substance use disorders.
(g) Authorization of Appropriations.--There are authorized to be
appropriated to carry out this section $5,700,000 in fiscal year 2016
and each of the 3 succeeding fiscal years.
TITLE IV--ADDRESSING COLLATERAL CONSEQUENCES
SEC. 401. CORRECTIONAL EDUCATION DEMONSTRATION GRANT PROGRAM.
Title I of the Omnibus Crime Control and Safe Streets Act of 1968
(42 U.S.C. 3711 et seq.) is amended--
(1) by redesignating part KK as part LL;
(2) by redesignating sections 3011 and 3012 as sections
3021 and 3022, respectively; and
(3) by inserting before part LL, as redesignated, the
following:
``PART KK--CORRECTIONAL EDUCATION DEMONSTRATION GRANT PROGRAM
``SEC. 3011. CORRECTIONAL EDUCATION DEMONSTRATION GRANT PROGRAM.
``(a) Definition.--In this section, the term `eligible entity'
means a State, unit of local government, nonprofit organization, or
Indian tribe.
``(b) Grant Program Authorized.--The Attorney General may make
grants of not more than $750,000 to eligible entities to design,
implement, and expand educational programs for offenders in prisons,
jails, and juvenile facilities, including to pay for--
``(1) basic education, secondary level academic education,
high school equivalency examination preparation, career
technical education, and English as a second language
instruction at the basic, secondary, or post-secondary levels,
for adult and juvenile populations;
``(2) screening and assessment of inmates to assess
education level, needs, occupational interest or aptitude, risk
level, and other needs, and case management services;
``(3) hiring and training of instructors and aides,
reimbursement of non-corrections staff and experts,
reimbursement of stipends paid to inmate tutors or aides, and
the costs of training inmate tutors and aides;
``(4) instructional supplies and equipment, including
occupational program supplies and equipment to the extent that
the supplies and equipment are used for instructional purposes;
``(5) partnerships and agreements with community colleges,
universities, and career technology education program
providers, including tuition payments;
``(6) certification programs providing recognized high
school equivalency certificates and industry recognized
credentials; and
``(7) technology solutions to--
``(A) meet the instructional, assessment, and
information needs of correctional populations; and
``(B) facilitate the continued participation of
incarcerated students in community-based education
programs after the students are released from
incarceration.
``(c) Application.--An eligible entity desiring a grant under this
section shall submit to the Attorney General an application in such
form and manner, at such time, and accompanied by such information as
the Attorney General specifies.
``(d) Priority Considerations.--In awarding grants under this
section, the Attorney General shall give priority to applicants that--
``(1) assess the level of risk and need of inmates,
including by--
``(A) assessing the need for English as a second
language instruction;
``(B) conducting educational assessments; and
``(C) assessing occupational interests and
aptitudes;
``(2) target educational services to assessed needs,
including academic and occupational at the basic, secondary, or
post-secondary level;
``(3) target career technology education programs to--
``(A) areas of identified occupational demand; and
``(B) employment opportunities in the communities
in which students are reasonably expected to reside
post-release;
``(4) include a range of appropriate educational
opportunities at the basic, secondary, and post-secondary
levels;
``(5) include opportunities for students to attain industry
recognized credentials;
``(6) include partnership or articulation agreements
linking institutional education programs with community sited
programs provided by adult education program providers and
accredited institutions of higher education, community
colleges, and vocational training institutions; and
``(7) explicitly include career pathways models offering
opportunities for incarcerated students to develop academic
skills, in-demand occupational skills and credentials,
occupational experience in institutional work programs or work
release programs, and linkages with employers in the community,
so that incarcerated students have opportunities to embark on
careers with strong prospects for both post-release employment
and advancement in a career ladder over time.
``(e) Requirements.--An eligible entity desiring a grant under this
section shall--
``(1) describe the evidence-based methodology and outcome
measurements that will be used to evaluate each program funded
with a grant under this section, and specifically explain how
such measurements will provide valid measures of the impact of
the program; and
``(2) describe how the program described in paragraph (1)
could be broadly replicated if demonstrated to be effective.
``(f) Control of Internet Access.--An entity that receives a grant
under this section shall restrict access to the Internet by prisoners,
as appropriate, to ensure public safety.
``SEC. 3012. AUTHORIZATION OF APPROPRIATIONS.
``There are authorized to be appropriated $5,000,000 to carry out
this part for fiscal years 2016 through 2020.''.
SEC. 402. REVISION OF FAFSA FORM.
Section 483 of the Higher Education Act of 1965 (20 U.S.C. 1090) is
amended by adding at the end the following:
``(i) Convictions.--The Secretary shall not include any question
about the conviction of an applicant for the possession or sale of
illegal drugs on the FAFSA (or any other form developed under
subsection (a)).''.
SEC. 403. NATIONAL TASK FORCE ON RECOVERY AND COLLATERAL CONSEQUENCES.
(a) Definition.--In this section, the term ``collateral
consequence'' means a penalty, disability, or disadvantage--
(1) imposed on an individual as a result of a criminal
conviction but not as part of the judgment of the court that
imposes the conviction; or
(2) that an administrative agency, official, or civil court
is authorized, but not required, to impose on an individual
convicted of a felony, misdemeanor, or other criminal offense.
(b) Establishment.--
(1) In general.--Not later than 30 days after the date of
enactment of this Act, the Secretary of Health and Human
Services (in this section referred to as the ``Secretary'')
shall establish a bipartisan task force to be known as the Task
Force on Recovery and Collateral Consequences (in this section
referred to as the ``Task Force'').
(2) Membership.--
(A) Total number of members.--The Task Force shall
include 10 members, who shall be appointed by the
Secretary in accordance with subparagraphs (B) and (C).
(B) Members of the task force.--The Task Force
shall include--
(i) members who have national recognition
and significant expertise in areas such as
health care, housing, employment, substance use
disorder, mental health, law enforcement, and
law;
(ii) not fewer than 2 members--
(I) who have personally experienced
substance abuse or addiction and are in
recovery; and
(II) not fewer than 1 one of whom
has benefited from medication assisted
treatment; and
(iii) to the extent practicable, members
who formerly served as elected officials at the
State and Federal levels.
(C) Timing.--The Secretary shall appoint the
members of the Task Force not later than 60 days after
the date on which the Task Force is established under
paragraph (1).
(3) Chairperson.--The Task Force shall select a chairperson
or co-chairpersons from among the members of the Task Force.
(c) Duties of the Task Force.--
(1) In general.--The Task Force shall--
(A) identify collateral consequences for
individuals with Federal or State drug convictions who
are in recovery for substance use disorder; and
(B) determine whether the collateral consequences
identified under subparagraph (A) unnecessarily delay
individuals in recovery from resuming their personal
and professional activities.
(2) Recommendations.--Not later than 180 days after the
date of the first meeting of the Task Force, the Task Force
shall develop recommendations for proposed legislative and
regulatory changes to reduce and, to the extent practicable,
eliminate the collateral consequences identified by the Task
Force under paragraph (1).
(3) Collection of information.--The Task Force shall hold
hearings, require the testimony and attendance of witnesses,
and secure information from any department or agency of the
United States in performing the duties under paragraphs (1) and
(2).
(4) Report.--Not later than 1 year after the date of the
first meeting of the Task Force, the Task Force shall submit a
report detailing the findings and recommendations of the Task
Force to--
(A) each relevant committee of Congress;
(B) the head of each relevant department or agency
of the United States;
(C) the President; and
(D) the Vice President.
TITLE V--ADDICTION AND TREATMENT SERVICES FOR WOMEN, FAMILIES, AND
VETERANS
SEC. 501. AUTHORITY TO AWARD COMPETITIVE GRANTS TO ADDRESS OPIOID AND
HEROIN ABUSE BY PREGNANT AND PARENTING FEMALE OFFENDERS.
Part MM of the Omnibus Crime Control and Safe Streets Act of 1968,
as amended by section 302, is amended by adding at the end the
following:
``SEC. 3038. AUTHORITY TO AWARD COMPETITIVE GRANTS TO ADDRESS OPIOID
AND HEROIN ABUSE BY PREGNANT AND PARENTING FEMALE
OFFENDERS.
``(a) Definitions.--In this section--
``(1) the term `State criminal justice agency' means the
agency of the State responsible for administering criminal
justice funds, including the Edward Byrne Memorial Justice
Assistance Grant Program under subpart 1 of part E; and
``(2) the term `State substance abuse agency' means the
agency of the State responsible for the State prevention,
treatment, and recovery system, including management of the
Substance Abuse Prevention and Treatment Block Grant under
subpart II of part B of title XIX of the Public Health Service
Act (42 U.S.C. 300x-21 et seq.).
``(b) Purpose and Program Authority.--
``(1) Grant authorization.--The Attorney General, in
coordination with the Secretary of Health and Human Services,
may award competitive grants jointly to a State substance abuse
agency and a State criminal justice agency to address the use
of opioids and heroin among pregnant and parenting female
offenders in the State to promote public safety, public health,
family permanence, and well-being.
``(2) Purposes and program authority.--A grant under this
section shall be used to facilitate or enhance collaboration
between the State criminal justice and State substance abuse
systems in order to carry out programs to address the use of
opioid and heroin abuse by pregnant and parenting female
offenders.
``(c) Applications.--
``(1) In general.--A State substance abuse agency and State
criminal justice agency desiring a grant under this section
shall jointly submit to the Attorney General an application in
such form, and containing such information, as the Attorney
General may prescribe by regulation or guidelines.
``(2) Contents.--
``(A) In general.--Each application for a grant
under this section shall contain a plan to expand the
services of the State for pregnant and parenting female
offenders for the use of opioids, heroin, and other
drugs, which shall be in accordance with regulations or
guidelines established by the Attorney General, in
consultation with the Secretary of Health and Human
Services.
``(B) Plan.--A plan submitted under subparagraph
(A) shall, at a minimum, include--
``(i) a description of how the applicants
will work jointly to address the needs
associated with the use of opioids or heroin by
pregnant and parenting female offenders to
promote family stability and permanence;
``(ii) a description of the nature and the
extent of the problem of opioid and heroin use
by pregnant and parenting female offenders in
the State;
``(iii) a certification that the State has
involved counties and other units of local
government, when appropriate, in the
development, expansion, modification,
operation, or improvement of proposed programs
to address the problems associated with opioid
and heroin use;
``(iv) a certification that funds received
under this section will be used to supplement,
not supplant, other Federal, State, and local
funds; and
``(v) a description of clinically
appropriate practices and procedures to--
``(I) screen and assess pregnant
and parenting female offenders for
problems associated with opioids and
heroin;
``(II) screen and assess pregnant
and parenting female offenders
demonstrating problems associated with
opioids and heroin for co-occurring
mental disorders;
``(III) provide clinically
appropriate services, including
medication assisted treatment, for
female offenders and their children in
the same location to promote family
permanence and self-sufficiency; and
``(IV) provide for a process to
enhance or ensure the abilities of the
State criminal justice agency and State
substance abuse agency to work together
to reunite families when appropriate in
the case where family treatment is not
provided.
``(d) Period of Grant; Renewal.--
``(1) Period.--A grant under this section shall be for a
period of 3 years.
``(2) Renewal.--A State substance abuse agency and a State
criminal justice agency receiving a grant under this section
may apply for and, after the end of the period of the first
grant under this section, receive 1 additional grant under this
section.
``(e) Performance Accountability; Reports.--
``(1) Reports.--A State substance abuse agency and a State
criminal justice agency receiving a grant under this section
shall jointly submit to the Attorney General a report on the
activities carried out under the grant at the end of each
fiscal year during the period of the grant.
``(2) Evaluation.--Not later than 1 year after the end of
the period of a grant under this section, the Attorney General
shall submit a report to each committee of Congress with
jurisdiction of the program under this section that summarizes
the reports of the recipients of the grant and provides
recommendations, if any, for further legislative action.
``(f) Training and Technical Assistance.--The Attorney General
shall support State substance abuse and State criminal justice agencies
by developing, in consultation with State substance abuse and State
criminal justice agencies, and offering a program of training and
technical assistance to assist the agencies in developing programs and
protocols--
``(1) to implement this section; and
``(2) for effectively working across the Federal and State
criminal and substance abuse systems.
``(g) Authorization of Appropriations.--There are authorized to be
appropriated to carry out this section $5,000,000 for each of fiscal
years 2016 through 2020.''.
SEC. 502. GRANTS FOR FAMILY-BASED SUBSTANCE ABUSE TREATMENT.
Section 2925 of the Omnibus Crime Control and Safe Streets Act of
1968 (42 U.S.C. 3797s-4) is amended--
(1) by striking ``An entity'' and inserting ``(a) Entity
Reports.--An entity''; and
(2) by adding at the end the following:
``(b) Attorney General Report on Family-Based Substance Abuse
Treatment.--The Attorney General shall submit to Congress an annual
report that describes the number of grants awarded under section
2921(1) and how such grants are used by the recipients for family-based
substance abuse treatment programs that serve as alternatives to
incarceration for custodial parents to receive treatment and services
as a family.''.
SEC. 503. VETERANS' TREATMENT COURTS.
Section 2991 of the Omnibus Crime Control and Safe Streets Act of
1968 (42 U.S.C. 3797aa) is amended--
(1) by redesignating subsection (i) as subsection (j);
(2) by inserting after subsection (h) the following:
``(i) Assisting Veterans.--
``(1) Definitions.--In this subsection:
``(A) Peer to peer services or programs.--The term
`peer to peer services or programs' means services or
programs that connect qualified veterans with other
veterans for the purpose of providing support and
mentorship to assist qualified veterans in obtaining
treatment, recovery, stabilization, or rehabilitation.
``(B) Qualified veteran.--The term `qualified
veteran' means a preliminarily qualified offender who--
``(i) has served on active duty in any
branch of the Armed Forces, including the
National Guard and reserve components; and
``(ii)(I) was discharged or released from
such service under conditions other than
dishonorable; or
``(II) was discharged or released from such
service under dishonorable conditions, if the
reason for that discharge or release, if known,
is attributable to drug use.
``(C) Veterans treatment court program.--The term
`veterans treatment court program' means a court
program involving collaboration among criminal justice,
veterans, and mental health and substance abuse
agencies that provides qualified veterans with--
``(i) intensive judicial supervision and
case management, which may include random and
frequent drug testing where appropriate;
``(ii) a full continuum of treatment
services, including mental health services,
substance abuse services, medical services, and
services to address trauma;
``(iii) alternatives to incarceration; and
``(iv) other appropriate services,
including housing, transportation, mentoring,
employment, job training, education, and
assistance in applying for and obtaining
available benefits.
``(2) Veterans assistance program.--
``(A) In general.--The Attorney General, in
consultation with the Secretary of Veterans Affairs,
may award grants under this subsection to applicants to
establish or expand--
``(i) veterans treatment court programs;
``(ii) peer to peer services or programs
for qualified veterans;
``(iii) practices that identify and provide
treatment, rehabilitation, legal, transitional,
and other appropriate services to qualified
veterans who have been incarcerated; and
``(iv) training programs to teach criminal
justice, law enforcement, corrections, mental
health, and substance abuse personnel how to
identify and appropriately respond to incidents
involving qualified veterans.
``(B) Priority.--In awarding grants under this
subsection, the Attorney General shall give priority to
applications that--
``(i) demonstrate collaboration between and
joint investments by criminal justice, mental
health, substance abuse, and veterans service
agencies;
``(ii) promote effective strategies to
identify and reduce the risk of harm to
qualified veterans and public safety; and
``(iii) propose interventions with
empirical support to improve outcomes for
qualified veterans.''; and
(3) in subsection (j), as so redesignated--
(A) by redesignating paragraph (2) as paragraph
(3); and
(B) by inserting after paragraph (1) the following:
``(2) Veterans treatment courts.--In addition to the
amounts authorized under paragraph (1), there are authorized to
be appropriated to the Attorney General $5,000,000 for each of
fiscal years 2016 through 2020 to carry out subsection (i).''.
TITLE VI--INCENTIVIZING STATE COMPREHENSIVE INITIATIVES TO ADDRESS
OPIOID AND HEROIN ABUSE
SEC. 601. STATE DEMONSTRATION GRANTS FOR COMPREHENSIVE OPIOID ABUSE
RESPONSE.
Part MM of the Omnibus Crime Control and Safe Streets Act of 1968,
as amended by section 501, is amended by adding at the end the
following:
``SEC. 3039. STATE DEMONSTRATION GRANTS FOR COMPREHENSIVE OPIOID ABUSE
RESPONSE.
``(a) Definitions.--In this section--
``(1) the term `dispenser' has the meaning given the term
in section 102 of the Controlled Substances Act (21 U.S.C.
802);
``(2) the term `prescriber of a schedule II, III, or IV
controlled substance' does not include a prescriber of a
schedule II, III, or IV controlled substance that dispenses the
substance--
``(A) for use on the premises on which the
substance is dispensed;
``(B) in a hospital emergency room, when the
substance is in short supply;
``(C) for a certified opioid treatment program; or
``(D) in other situations as the Attorney General
may reasonably determine;
``(3) the term `prescriber' means a dispenser who
prescribes a controlled substance, or the agent of such a
dispenser; and
``(4) the term `schedule II, III, or IV controlled
substance' means a controlled substance that is listed on
schedule II, schedule III, or schedule IV of section 202(c) of
the Controlled Substances Act (21 U.S.C. 812(c)).
``(b) Planning and Implementation Grants.--
``(1) In general.--The Attorney General, in coordination
with the Secretary of Health and Human Services and the
Director of the Office of National Drug Control Policy, may
award grants to States, and combinations thereof, to prepare a
comprehensive plan for and implement an integrated opioid abuse
response initiative.
``(2) Purposes.--A State receiving a grant under this
section shall establish a comprehensive response to opioid
abuse, which shall include--
``(A) prevention and education efforts around
heroin and opioid use, treatment, and recovery;
``(B) a comprehensive prescription drug monitoring
program to track dispensing of schedule II, III, or IV
controlled substances, which shall include--
``(i) data sharing with other States by
statute, regulation, or interstate agreement;
and
``(ii) educating physicians, residents,
medical students, and other prescribers of
Schedule II, III, or IV controlled substances
on the prescription drug monitoring program of
the State;
``(C) developing, implementing, or expanding the
prescription drug and opioid addiction treatment
program of the State by--
``(i) expanding programs for medication
assisted treatment of prescription drug and
opioid addiction, including training for
treatment and recovery support providers;
``(ii) developing, implementing, or
expanding programs for behavioral health
therapy for individuals who are in treatment
for prescription drug and opioid addiction,
including contingency management, cognitive
behavioral therapy, and motivational
enhancements;
``(iii) developing, implementing, or
expanding programs to screen individuals who
are in treatment for prescription drug and
opioid addiction for hepatitis C and HIV, and
provide treatment for those individuals if
clinically appropriate; or
``(iv) developing, implementing, or
expanding programs that provide screening,
early intervention, and referral to treatment
(commonly referred to as `SBIRT') to teenagers
and young adults in primary care, middle
schools, high schools, universities, school-
based health centers, and other community-based
health care settings frequently accessed by
teenagers or young adults; and
``(D) developing, implementing, and expanding
programs to prevent overdose death of prescription
medications and opioids.
``(3) Planning grant applications.--
``(A) Application.--
``(i) In general.--A State desiring a
planning grant under this section to prepare a
comprehensive plan for an integrated opioid
abuse response initiative shall submit to the
Attorney General an application in such form,
and containing such information, as the
Attorney General may prescribe by regulation or
guidelines.
``(ii) Requirements.--An application for a
planning grant under this section shall, at a
minimum, include--
``(I) a budget and a budget
justification for the activities to be
carried out using the grant;
``(II) a description of the
activities proposed to be carried out
using the grant, including a schedule
for completion of such activities;
``(III) outcome measures that will
be used to measure the effectiveness of
the programs and initiatives to address
opioids; and
``(IV) a description of the
personnel necessary to complete such
activities.
``(B) Period; nonrenewability.--A planning grant
under this section shall be for a period of 1 year. A
State may not receive more than 1 planning grant under
this section.
``(C) Amount.--A planning grant under this section
may not exceed $100,000, except that the Attorney
General may, for good cause, approve a grant in a
higher amount.
``(D) Strategic plan and program implementation
plan.--A State receiving a planning grant under this
section shall develop a strategic plan and a program
implementation plan.
``(4) Implementation grants.--
``(A) Application.--A State desiring an
implementation grant under this section to implement a
comprehensive strategy for addressing opioid abuse
shall submit to the Attorney General an application in
such form, and containing such information, as the
Attorney General may prescribe by regulation or
guidelines.
``(B) Use of funds.--A State that receives an
implementation grant under this section shall use the
grant for the cost of carrying out an integrated opioid
abuse response program in accordance with this section,
including for technical assistance, training, and
administrative expenses.
``(C) Requirements.--An integrated opioid abuse
response program carried out using an implementation
grant under this section shall--
``(i) ensure that each prescriber of a
schedule II, III, or IV controlled substance in
the State--
``(I) registers with the
prescription drug monitoring program of
the State; and
``(II) consults the prescription
drug monitoring program database of the
State before prescribing a schedule II,
III, or IV controlled substance;
``(ii) ensure that each dispenser of a
schedule II, III, or IV controlled substance in
the State--
``(I) registers with the
prescription drug monitoring program of
the State;
``(II) consults the prescription
drug monitoring program database of the
State before dispensing a schedule II,
III, or IV controlled substance; and
``(III) reports to the prescription
drug monitoring program of the State,
at a minimum, each instance in which a
schedule II, III, or IV controlled
substance is dispensed, with limited
exceptions, as defined by the State,
which shall indicate the prescriber by
name and National Provider Identifier;
``(iii) require that, not fewer than 4
times each year, the State agency or agencies
that administer the prescription drug
monitoring program of the State prepare and
provide to each prescriber of a schedule II,
III, or IV controlled substance an
informational report that shows how the
prescribing patterns of the prescriber compare
to prescribing practices of the peers of the
prescriber and expected norms;
``(iv) if informational reports provided to
a prescriber under clause (iii) indicate that
the prescriber is repeatedly falling outside of
expected norms or standard practices for the
prescriber's field, direct the prescriber to
educational resources on appropriate
prescribing of controlled substances;
``(v) ensure that the prescriber licensing
board of the State receives a report describing
any prescribers that repeatedly fall outside of
expected norms or standard practices for the
prescriber's field, as described in clause
(iii);
``(vi) require consultation with the Single
State Authority for Substance Abuse; and
``(vii) establish requirements for how data
will be collected and analyzed to determine the
effectiveness of the program.
``(D) Period.--An implementation grant under this
section shall be for a period of 2 years.
``(E) Amount.--The amount of an implementation
grant under this section may not exceed $5,000,000
except that the Attorney General may, for good cause,
approve a grant in a higher amount.
``(5) Priority considerations.--In awarding planning and
implementation grants under this section, the Attorney General
shall give priority to a State that--
``(A) provides civil liability protection for first
responders, health professionals, and family members
administering naloxone to counteract opioid overdoses
by--
``(i) enacting legislation that provides
such civil liability protection; or
``(ii) providing a certification by the
attorney general of the State that the attorney
general has--
``(I) reviewed any applicable civil
liability protection law to determine
the applicability of the law with
respect to first responders, health
care professionals, family members, and
other individuals who may administer
naloxone to individuals reasonably
believed to be suffering from opioid
overdose; and
``(II) concluded that the law
described in subclause (I) provides
adequate civil liability protection
applicable to such persons;
``(B) have in effect legislation or implement a
policy under which the State shall not terminate, but
may suspend, enrollment under the State plan for
medical assistance under title XIX of the Social
Security Act (42 U.S.C. 1396 et seq.) for an individual
who is incarcerated for a period of fewer than 2 years;
``(C) have a process for enrollment in services and
benefits necessary by criminal justice agencies to
initiate or continue treatment in the community, under
which an individual who is incarcerated may, while
incarcerated, enroll in services and benefits that are
necessary for the individual to continue treatment upon
release from incarceration;
``(D) ensures the capability of data sharing with
other States, such as by making data available to a
prescription monitoring hub;
``(E) ensures that data recorded in the
prescription drug monitoring program database of the
State is available within 24 hours, to the extent
possible; and
``(F) ensures that the prescription drug monitoring
program of the State notifies prescribers and
dispensers of schedule II, III, or IV controlled
substances when overuse or misuse of such controlled
substances by patients is suspected.
``(c) Authorization of Appropriations.--There are authorized to be
appropriated to carry out this section $15,000,000 for each of fiscal
years 2016 through 2020.''.
TITLE VII--OFFSET; GAO REPORT
SEC. 701. OFFSET.
It is the sense of Congress that the amounts expended to carry out
this Act and the amendments made by this Act should be offset by a
corresponding reduction in Federal non-defense discretionary spending.
SEC. 702. GAO REPORT ON IMD EXCLUSION.
(a) Definition.--In this section, the term ``Medicaid Institutions
for Mental Disease exclusion'' means the prohibition on Federal
matching payments under Medicaid for patients who have attained age 22,
but have not attained age 65, in an institution for mental diseases
under subparagraph (B) of the matter following subsection (a) of
section 1905 of the Social Security Act and subsection (i) of such
section (42 U.S.C. 1396d).
(b) Report Required.--Not later than 180 days after the date of
enactment of this Act, the Comptroller General of the United States
shall submit to Congress a report on the impact that the Medicaid
Institutions for Mental Disease exclusion has on access to treatment
for individuals with a substance use disorder.
(c) Elements.--The report required under subsection (b) shall
include the following:
(1) An analysis of whether the following policy changes to
the Medicaid Institutions for Mental Disease exclusion would
enhance access to treatment for individuals with a substance
use disorder:
(A) Removing substance use disorder treatment and
facilities from the Medicaid Institutions for Mental
Disease exclusion.
(B) Amending section 1905(i) of the Social Security
Act (42 U.S.C. 1396d(i)) to modestly raise the 16-bed
limit in the definition of an institution for mental
diseases under that section.
(C) Repealing the Medicaid Institutions for Mental
Disease exclusion.
(2) An analysis of whether and to what extent the quality
of care for substance use disorder treatment is impacted by the
Medicaid Institutions for Mental Disease exclusion.
(3) An analysis of barriers in accessing State-specific
information related to the impact of the Medicaid Institutions
for Mental Disease exclusion on access to treatment.
(4) An analysis of the difference in cost between treatment
for a substance use disorder in a hospital setting compared to
a community-based care setting.
(5) An analysis of the characteristics of institutions for
mental diseases (as defined in section 1905(i) of the Social
Security Act (42 U.S.C. 1396d(i))), including the patient
capacity of such institutions as well as the type of care
setting, among other characteristics.
<all>